The Latest Breaking News from Palantir

Thursday options trading had nine unusually active call options with more than 365 days to expiration. While they all look intriguing, here are the three to focus on if you’ve got some time to kill.

With the tech landscape increasingly dominated by AI stocks, can Palantir break out in the back of this year?

Palantir Technologies shares have gained over 50% year-to-date amid the AI boom as revenue from government contracts and commercial clients continues to increase steadily.

When US tech giant Palantir signed a £330 million contract with the NHS to operate its data platform, some sounded the alarm over patient privacy.

These two growth stocks appear to be well-positioned to capitalize on the AI wave.

Down about 38% from all-time highs, Palantir trades at a discount, especially if the AI software specialist can grow its earnings at a stellar pace going forward.

The mega-cap chipmaker shed more than 4% this week, creating headwinds for the S&P 500 and Nasdaq.

Shorting out-of-the-money puts in Palantir stock might be a good income opportunity. It could also be a good buy-in point in PLTR stock. This is based on a higher target price based on its strong FCF.

Palantir Technologies stock is attracting attention with its impressive AI-driven growth, major contracts, and partnerships, but its high valuation and mixed analyst sentiment raise questions about the sustainability of its rally and the likelihood of a significant breakout in the near term.

With the market back in bullish mode for now, it’s a good time to run Barchart’s Bull Call Spread Screener.

Top AI engineers at defence technology companies defended the need for autonomous weapons on Thursday, amid a push for a ban on so-called "killer robots". More than 115 countries and 250 non-governmental organisations are calling for an international treaty to ban weapons that use artificial intelligence to identify and engage…